ABBEY_D._SURGERY_LTD - Accounts


Company Registration No. 06544621 (England and Wales)
ABBEY D. SURGERY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
PAGES FOR FILING WITH REGISTRAR
ABBEY D. SURGERY LTD
COMPANY INFORMATION
Directors
Mr A Anand
Dr P Anand
Secretary
Ms G Anand
Company number
06544621
Registered office
90 Packhorse Road
Gerrards Cross
United Kingdom
SL9 8JG
Accountants
RDP Newmans LLP
Lynwood House
373-375 Station Road
Harrow
Middlesex
HA1 2AW
ABBEY D. SURGERY LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
ABBEY D. SURGERY LTD
BALANCE SHEET
AS AT
31 MARCH 2021
31 March 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Intangible assets
3
67,497
101,246
Tangible assets
4
41,884
47,361
109,381
148,607
Current assets
Stocks
2,723
2,444
Debtors
5
61,679
1,316,673
Cash at bank and in hand
714,297
391,135
778,699
1,710,252
Creditors: amounts falling due within one year
6
(106,453)
(324,529)
Net current assets
672,246
1,385,723
Total assets less current liabilities
781,627
1,534,330
Creditors: amounts falling due after more than one year
7
(50,000)
(50,000)
Provisions for liabilities
(7,958)
(8,999)
Net assets
723,669
1,475,331
Capital and reserves
Called up share capital
8
1,000
1,000
Profit and loss reserves
722,669
1,474,331
Total equity
723,669
1,475,331

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

ABBEY D. SURGERY LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2021
31 March 2021
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 31 December 2021 and are signed on its behalf by:
Dr P Anand
Director
Company Registration No. 06544621
ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
- 3 -
1
Accounting policies
Company information

Abbey D. Surgery Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 90 Packhorse Road, Gerrards Cross, United Kingdom, SL9 8JG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised in the period in which the service was performed.

1.3
Intangible fixed assets - goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business.

Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
18% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 4 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 6 -
1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
17
16
ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 7 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2020 and 31 March 2021
490,000
Amortisation and impairment
At 1 April 2020
388,754
Amortisation charged for the year
33,749
At 31 March 2021
422,503
Carrying amount
At 31 March 2021
67,497
At 31 March 2020
101,246
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2020
238,892
Additions
3,717
At 31 March 2021
242,609
Depreciation and impairment
At 1 April 2020
191,531
Depreciation charged in the year
9,194
At 31 March 2021
200,725
Carrying amount
At 31 March 2021
41,884
At 31 March 2020
47,361
5
Debtors
2021
2020
Amounts falling due within one year:
£
£
Trade debtors
59,456
56,549
Other debtors
2,223
1,260,124
61,679
1,316,673
ABBEY D. SURGERY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 8 -
6
Creditors: amounts falling due within one year
2021
2020
£
£
Trade creditors
870
472
Amounts owed to group undertakings
-
0
58,620
Taxation and social security
83,442
28,720
Other creditors
22,141
236,717
106,453
324,529
7
Creditors: amounts falling due after more than one year
2021
2020
£
£
Bank loans and overdrafts
50,000
-
0
Other creditors
-
0
50,000
50,000
50,000
8
Called up share capital
2021
2020
£
£
Ordinary share capital
Issued and fully paid
450 Ordinary 'A' of £1 each
450
450
200 Ordinary 'B' of £1 each
200
200
350 Ordinary 'C' of £1 each
350
350
1,000
1,000

Ordinary 'A', Ordinary 'B' and Ordinary 'C' shares rank pari passu in all respects.

2021-03-312020-04-01false31 December 2021CCH SoftwareCCH Accounts Production 2021.300No description of principal activityMr A AnandDr P AnandMs G Anand065446212020-04-012021-03-3106544621bus:Director12020-04-012021-03-3106544621bus:Director22020-04-012021-03-3106544621bus:CompanySecretary12020-04-012021-03-3106544621bus:RegisteredOffice2020-04-012021-03-31065446212021-03-3106544621core:NetGoodwill2021-03-3106544621core:NetGoodwill2020-03-31065446212019-04-012020-03-31065446212020-03-3106544621core:OtherPropertyPlantEquipment2021-03-3106544621core:OtherPropertyPlantEquipment2020-03-3106544621core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3106544621core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3106544621core:Non-currentFinancialInstrumentscore:AfterOneYear2021-03-3106544621core:Non-currentFinancialInstrumentscore:AfterOneYear2020-03-3106544621core:CurrentFinancialInstruments2021-03-3106544621core:CurrentFinancialInstruments2020-03-3106544621core:Non-currentFinancialInstruments2021-03-3106544621core:Non-currentFinancialInstruments2020-03-3106544621core:ShareCapital2021-03-3106544621core:ShareCapital2020-03-3106544621core:RetainedEarningsAccumulatedLosses2021-03-3106544621core:RetainedEarningsAccumulatedLosses2020-03-3106544621core:ShareCapitalOrdinaryShares2021-03-3106544621core:ShareCapitalOrdinaryShares2020-03-3106544621core:Goodwill2020-04-012021-03-3106544621core:FurnitureFittings2020-04-012021-03-3106544621core:NetGoodwill2020-03-3106544621core:NetGoodwill2020-04-012021-03-3106544621core:OtherPropertyPlantEquipment2020-03-3106544621core:OtherPropertyPlantEquipment2020-04-012021-03-3106544621core:WithinOneYear2021-03-3106544621core:WithinOneYear2020-03-3106544621bus:PrivateLimitedCompanyLtd2020-04-012021-03-3106544621bus:SmallCompaniesRegimeForAccounts2020-04-012021-03-3106544621bus:FRS1022020-04-012021-03-3106544621bus:AuditExemptWithAccountantsReport2020-04-012021-03-3106544621bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP